GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                                                                Synonyms: SB-240683
                                 Compound class: 
                                                            Antibody
                                 
                                    
                                        Comment: Pascolizumab targets interleukin 4 (IL4).
                                    
                                 | 
| No information available. | 
| Summary of Clinical Use  | 
| Pascolizumab is in Phase 2 clinical trial for asthma (see NCT00024544) and pulmonary tuberculosis (TB; see NCT01638520). |